Happy Thanksgiving from Pioneer Institute!

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

As we welcome the holiday season, I would like to thank you for everything you do with and for Pioneer. We are grateful for your support today and everyday. We are grateful for a nation that has shown incredible resilience in recovering from a global pandemic. For innovation in the life sciences to develop and distribute vaccines. For learning pods, homeschooling, and private and parochial models that have kept our kids engaged, whether in-person or remote. For telehealth and regulatory changes to give patients greater access to medical care. For the MBTA’s commitment to infrastructure investments to improve service for the Bay State’s one million commuters. Lastly, for a business community that has overcome the challenge of extended closures, is now contending with unprecedented labor and supply shortages – and will soon face the threat of a ballot measure that could impose a major state tax increase. With your continued support, Pioneer will remain active on these issues and many more.

As we gather with family and friends this Thanksgiving, I want to encourage our community to be part of bringing our country back together, one dinner table at a time. Let’s remember that political conversations are not taboo, only those long on anger and short on policy substance. Let’s be grateful for the opportunity to be with loved ones, for all we have—and, most of all, for our freedoms.

Happy Thanksgiving,
Jim Stergios, Executive Director

PS – Giving Tuesday is around the corner. If you’d like to get a jump on making your end of year donation, you can do so here!

Recent Posts:

Exploiting Charity Drugs: Hospital Program Earns Billions But Forgets Mission

Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Dr. Bill Smith about his recently released paper entitled, "340B Drug Discounts, An Increasingly Dysfunctional Federal Program," which analyzes the evolution of a well-intentioned program to offer discounted drugs to the uninsured from a benefit that had helped charitable hospitals to one that has exploded to generate billions in profits while serving fewer uninsured.

Attorney – PioneerLegal

PioneerLegal is hiring an attorney to work on cases at every stage of the litigation process, from trial to appeals in state and federal court, and prepare amicus briefs for the U.S. Supreme Court (where Pioneer Institute already has a winning track record) and the highest appellate courts throughout New England.  This role will perform legal and factual research to identify litigation opportunities that align with our mission, developing case proposals for our litigation intake review process. 

NYU’s Dr. Arthur Levine on Higher Education’s Future & Improving K-12 Teacher Preparation

/
This week on “The Learning Curve," co-hosts Cara Candal and Gerard Robinson talk with Dr. Arthur Levine, a scholar with New York University's Steinhardt Institute for Higher Education Policy, a senior fellow and president emeritus of the Woodrow Wilson National Fellowship Foundation, and president emeritus of Columbia University's Teachers College. He shares the main findings and recommendations of a new book he recently co-authored, The Great Upheaval: Higher Education’s Past, Present, and Uncertain Future.

Rent Control Redux: Mayor’s Committee Likely to Provide Astroturf Over Expertise

Hubwonk host Joe Selvaggi talks with Doug Quatrocchi, executive director of Masslandlords.net about the historical effects of rent control in Boston and Cambridge in the past and discuss the gap between the stated goals and the likely outcome of Boston Mayor Wu’s 25 member Rent Stabilization Advisory Committee.

Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes

Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.

Avak Kahvejian on How Immigrants Drive Innovation

This week on JobMakers, host Denzil Mohammed talks with Dr. Avak Kahvejian, an inventor, entrepreneur and CEO as well as general partner at Flagship Pioneering, a life sciences venture capital company in Cambridge, Massachusetts.